CD19-CAR-DNT cells (RJMty19) in patients with relapsed or refractory large B-cell lymphoma: a phase 1, first-in-human study.

Xibin Xiao; Hui Liu; Xi Qiu; Panpan Chen; Xian Li; Dan Wang; Guangrong Song; Yu Cheng; Liming Yang; Wenbin Qian

doi:10.1016/j.eclinm.2024.102516

CD19-CAR-DNT cells (RJMty19) in patients with relapsed or refractory large B-cell lymphoma: a phase 1, first-in-human study.

Identifier:nobleid.org/w1/20260515/CF9737FB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF9737FB.svg?ark=w1%2F20260515%2FCF9737FB)](https://nobleid.org/work/w1/20260515/CF9737FB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CD19-CAR-DNT cells (RJMty19) in patients with relapsed or refractory large B-cell lymphoma: a phase 1, first-in-human study.

Identifier:nobleid.org/w1/20260515/CF9737FB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF9737FB.svg?ark=w1%2F20260515%2FCF9737FB)](https://nobleid.org/work/w1/20260515/CF9737FB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work